Health Care Market News Revive Therapeutics (CSE:RVV) updates on Phase 3 clinical study for Bucillamine Revive Therapeutics (RVV) has announced an update on the Phase 3 clinical trial of Bucillamine for... Research2 mins20 March 2023 12:03 (EDT)
Health Care Market News Revive Therapeutics (CSE:RVV) revising Bucillamine study endpoints Revive Therapeutics (RVV) has provided an update regarding its Bucillamine phase three study requirements from the... Caroline Egan2 mins08 March 2023 11:00 (EDT)
Health Care Market News Psychedelics PharmAla (CSE:MDMA) named exclusive MDMA supplier to Revive Therapeutics (CSE:RVV) PharmAla Biotech Holdings Inc. (MDMA) has signed an agreement to be Revive Therapeutics' (RVV) exclusive supplier... Caroline Egan2 mins06 February 2023 14:45 (EDT)
Health Care Market News Psychedelics Revive Therapeutics (CSE:RVV) & PharmaTher (CSE:PHRM) sign MDMA research collaboration agreement Revive Therapeutics (RVV) and PharmaTher (PHRM) signed a research collaboration agreement to evaluate the delivery of... Jonathon Brown2 mins03 February 2023 12:15 (EDT)
Health Care Market News Revive Therapeutics (CSE:RVV) closes $4.3M private placement Revive Therapeutics (RVV) has closed a private placement for gross proceeds of $4.3 million The company... John Ballem1 min12 January 2023 08:45 (EDT)
Health Care The Market Online Deal Room Revive Therapeutics (CSE:RVV) announces $5M private placement Revive Therapeutics (RVV) has announced a private placement for gross proceeds of between $3 million and... John Ballem1 min01 December 2022 08:45 (EDT)
Health Care Revive Therapeutics (CSE:RVV) updates Bucillamine in treating COVID-19 Revive Therapeutics Ltd. (RVV) has announced an update of its Food and Drug Administration (FDA) phase... Caroline Egan2 mins06 October 2022 15:30 (EDT)
Health Care Revive Therapeutics (CSE:RVV) updates phase I/II clinical study of oral psilocybin Revive Therapeutics has provided an update on its clinical study of oral psilocybin in the treatment... John Ballem2 mins16 September 2022 09:15 (EDT)
Health Care Revive Therapeutics (CSE:RVV) submits amended Phase 3 COVID-19 study protocol to FDA Revive Therapeutics (RVV) has filed an amended protocol to the U.S. Food & Drug Administration for... John Ballem2 mins14 September 2022 08:45 (EDT)
Cannabis Health Care Psychedelics Update from Revive Therapeutics (CSE:RVV) on Phase 3 clinical trial for Bucillamine in COVID-19 Revive Therapeutics (RVV) has provided an update on the company’s U.S. Food & Drug Administration (FDA)... John Ballem2 mins16 August 2022 10:15 (EDT)
